The Latest Breaking News from Civica

California's Insulin Program Still Has No Vials, No Fast Acting Product and No Factory of Its Own

CalRx sells $55 insulin pens, but vials, rapid-acting insulin, and state manufacturing are all still pending. Here is what exists now.

Medical Daily · Aug 24

California Shipped 120,000 Packs of $55 Insulin but Cannot Say How Many Patients Actually Received Them

California distributed 120,000 packs of $55 CalRx insulin but does not track dispensing. Here is what patients should ask at the pharmacy.

Medical Daily · Aug 18

California to begin selling affordable state-branded insulin beginning next year

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell state-branded generic drugs at lower prices

The Independent UK · Oct 16, 2025

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

SACRAMENTO, Calif. — California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices to people with diabetes like Sabrina Caudillo.

Tribune News Service · Jun 9, 2022

Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes

Doctors have been treating diabetes with insulin since 1922. A century later, about 1 in 5 of the 37 million Americans living with diabetes take this medication – a hormone that helps cells absorb sugar from the blood.

The Conversation · May 9, 2022